about
Why Enosium Life Science
OUR Purpose
Meeting the challenges of health innovation
Pharmaceutical, biotechnology, and medtech companies face major challenges in commercializing their health products and innovations.
Acceleration of scientific and technological innovation
High R&D costs and associated risks
Complexity, fragmentation, and uncertainties of EU regulations
Limited funding and pressure on access prices
Growing societal demand for healthcare
Integrated services across the entire value chain
founder & ceo
Antoine Amer, MD
Antoine Amer, 50 years old, a physician holding an MBA from ESCP and Harvard Business School, has over 20 years of experience in the pharmaceutical industry. He has led commercial operations in Europe and globally for renowned pharmaceutical companies: MSD, Servier, AbbVie, and Indivior.
As the CEO of Enosium Life Science, his mission is to bring together the best scientific services companies to create a leading group in Europe within the next 5 years.
Our expertise
Otium : a major player in private investment in Europe
Learn more about Otium
